Doshi Dipal 4

What Happened

• Dipal Doshi, CEO and Director of Entrada Therapeutics (TRDA), received two awards of restricted stock units (RSUs) on 2026-03-01 totaling 347,400 RSUs (139,400 and 208,000). Both grants are reported at $0.00 (award/derivative acquisition).
• To satisfy withholding obligations, 29,050 shares were automatically sold: 9,869 shares on 2026-03-02 at a weighted average price of $11.66 ($115,052) and 19,181 shares on 2026-03-03 at a weighted average price of $11.76 ($225,500). Total proceeds ≈ $340,552. These sales were mandatory sell-to-cover transactions (not discretionary trades).

Key Details

• Transaction dates and prices:
  • RSU grants: 2026-03-01 — 139,400 RSUs and 208,000 RSUs (both reported at $0.00).
  • Shares sold (tax withholding): 2026-03-02 — 9,869 shares @ weighted avg $11.66 (range $11.17–$11.91); 2026-03-03 — 19,181 shares @ weighted avg $11.76 (range $11.22–$12.095).
• Shares sold to cover taxes totaled 29,050 shares for ≈ $340,552.
• Shares owned after the transactions: Not specified in the filing.
• Relevant footnotes:
  • F1: These RSUs represent the contingent right to receive one share per RSU; vesting: 25% on March 1 of 2027–2030, subject to continued service.
  • F2: The share sales were automatic sell-to-cover required to meet minimum statutory tax withholding — not discretionary sales by the reporting person.
  • F3/F4: Weighted-average price disclosures; specific per-share price breakdowns available on request.
  • F5: (Related vesting schedule language for option grants noted in filing.)
• Filing timeliness: The Form 4 was filed 2026-03-03 for transactions beginning 2026-03-01; the filing does not indicate a late filing.

Context

• These were RSU awards (contingent rights to future shares) rather than open-market purchases — awarding RSUs is a compensation event, not a buy signal. The subsequent sales were routine sell-to-cover transactions to satisfy tax withholding obligations and should not be read as discretionary insider selling.
• For retail investors: awards increase potential future insider ownership if RSUs vest; automatic sell-to-cover reduces immediate share count but is common after equity awards and does not necessarily indicate management sentiment about the stock.